Arrowhead Pharmaceuticals (Germany) Today
| HDP1 Stock | EUR 21.04 0.36 1.68% |
Performance6 of 100
| Odds Of DistressOver 62
|
Arrowhead Pharmaceuticals is trading at 21.04 as of the 17th of December 2024. This is a 1.68 percent decrease since the beginning of the trading day. The stock's lowest day price was 21.04. Arrowhead Pharmaceuticals has more than 62 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. ARROWHEAD PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 108.31 M outstanding shares. More on Arrowhead Pharmaceuticals
Moving against Arrowhead Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Arrowhead Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arrowhead Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arrowhead Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Christopher Anzalone |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Arrowhead Pharmaceuticals (HDP1) is traded on Frankfurt Exchange in Germany and employs 397 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arrowhead Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Arrowhead Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arrowhead Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 108.31 M outstanding shares.
Arrowhead Pharmaceuticals has accumulated about 218.2 M in cash with (136.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3.
Check Arrowhead Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationArrowhead Pharmaceuticals holds a total of 108.31 Million outstanding shares. Over half of Arrowhead Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Arrowhead Pharmaceuticals. Please watch out for any change in the institutional holdings of Arrowhead Pharmaceuticals as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arrowhead Ownership Details
Arrowhead Pharmaceuticals Risk Profiles
Although Arrowhead Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Arrowhead Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.91 | |||
| Semi Deviation | 3.56 | |||
| Standard Deviation | 4.69 | |||
| Variance | 22.03 |
Arrowhead Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arrowhead Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Arrowhead Pharmaceuticals Corporate Management
Elected by the shareholders, the Arrowhead Pharmaceuticals' board of directors comprises two types of representatives: Arrowhead Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arrowhead. The board's role is to monitor Arrowhead Pharmaceuticals' management team and ensure that shareholders' interests are well served. Arrowhead Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arrowhead Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tracie Oliver | Chief Officer | Profile | |
| Kenneth Myszkowski | Chief Officer | Profile | |
| Javier MD | Chief Officer | Profile | |
| PharmD JD | COO Counsel | Profile | |
| Howard Lovy | Director Communications | Profile | |
| Vincent CFA | Head VP | Profile |
Additional Information and Resources on Investing in Arrowhead Stock
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.